Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study

Mercè Grau‐Pérez, Laura Rodríguez‐Aguilar, Gastón Roustán, Fernando Alfageme

2022Journal of the European Academy of Dermatology and Venereology12 citationsDOI

Topics & Concepts

MedicineAdalimumabHidradenitis suppurativaBiosimilarRetrospective cohort studyInternal medicineCohortDermatologyDiseaseHidradenitis Suppurativa and TreatmentsMicroscopic ColitisColorectal and Anal Carcinomas